Los anticoagulantes orales de acción directa en el tratamiento de la enfermedad tromboembólica venosa asociada a cáncer

Franco Moreno, Ana Isabel; Cabezón Gutiérrez, Luis; García Navarro, María José.
Med. clín (Ed. impr.) ; 153(3): 122-125, ago. 2019. tab
Artículo en Español | IBECS (España) | ID: ibc-183435

Documentos relacionados

  1. Risk of Venous Thromboembolism by Cancer Type: A Network Meta-Analysis.
  2. Accuracy of the Ottawa score in risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism: a systematic review and meta-analysis.
  3. Updates in the Incidence, Pathogenesis, and Management of Cancer and Venous Thromboembolism.
  4. Thromboprophylaxis for inpatient with advanced cancer receiving palliative care: A retrospective study.
  5. Epidemiology, clinical profile and treatment patterns of venous thromboembolism in cancer patients in Taiwan: a population-based study.
  6. Prognostic Factors Associated With Development of Venous Thromboembolism in Critically Ill Patients-A Systematic Review and Meta-Analysis.
  7. Direct oral anticoagulants for cancer-associated venous thromboembolisms: a systematic review and network meta-analysis.
  8. Predictors of recurrence of cancer-associated venous thromboembolism after discontinuation of anticoagulant therapy: a multicenter cohort study.
  9. Treatment of venous thromboembolism in pediatric patients.
  10. Health Literacy and Treatment Satisfaction Among Patients with Venous Thromboembolism.